Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: A multicenter prospective cohort study

American Journal of Kidney Diseases

Volumn 64, Issue 5, 2014, Pages 744-752

  Minutolo, Roberto ^a   Gabbai, Francis B ^b   Agarwal, Rajiv ^c   Chiodini, Paolo ^a   Borrelli, Silvio ^a   Bellizzi, Vincenzo ^d   Nappi, Felice ^e   Stanzione, Giovanna ^a   Conte, Giuseppe ^a   De Nicola, Luca ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University Hospital   (Italy)

^e Nephrology Division   (Italy)

Author keywords

ambulatory blood pressure (BP); blood pressure control; blood pressure goal; cardiorenal risk; clinic blood pressure; Index Words Chronic kidney disease (CKD); masked hypertension; white coat hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AMBULATORY BLOOD PRESSURE; AMPUTATION; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIORENAL RISK; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINIC BLOOD PRESSURE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PERIPHERAL VASCULAR DISEASE; PROGNOSIS; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; REVASCULARIZATION; RISK; RISK ASSESSMENT; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; STANDARDS; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84908477794     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.06.014     Document Type: Article

References (39)

1. P.A. Sarafidis, S. Li, and S.C. Chen Hypertension awareness, treatment, and control in chronic kidney disease Am J Med 121 4 2008 332 340
2. P.A. James, S. Oparil, and B.L. Carter 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 5 2014 507 520
3. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease Kidney Int Suppl 2 2012 337 414
4. ESH/ESC Task Force for the Management of Arterial Hypertension 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension J Hypertens 31 10 2013 1925 1938
5. L. De Nicola, R. Minutolo, P. Chiodini for the TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention Kidney Int 69 3 2006 538 545
6. M.J. Landray, J.R. Emberson, and L. Blackwell Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study Am J Kidney Dis 56 6 2010 1082 1094
7. M.J. Andersen, W. Khawandi, and R. Agarwal Home blood pressure monitoring in CKD Am J Kidney Dis 45 6 2005 994 1001
8. V.M. Campese, N. Mitra, and D. Sandee Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney Int 69 6 2006 967 973
9. L. De Nicola, R. Minutolo, and V. Bellizzi Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am J Kidney Dis 43 5 2004 782 795
10. T.G. Pickering, G.D. James, C. Boddie, G.A. Harshfield, S. Blank, and J.H. Laragh How common is white coat hypertension? JAMA 259 2 1988 225 228
11. T.G. Pickering, K. Davidson, W. Gerin, and J.E. Schwartz Masked hypertension Hypertension 40 6 2002 795 796
12. F. Bangash, and R. Agarwal Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis Clin J Am Soc Nephrol 4 3 2009 656 664
13. R.H. Fagard, and V.A. Cornelissen Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis J Hypertens 25 11 2007 2193 2198
14. T.W. Hansen, M. Kikuya, and L. Thijs Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals J Hypertens 25 8 2007 1554 1564
15. S.D. Pierdomenico, and F. Cuccurullo Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis Am J Hypertens 24 1 2011 52 58
16. R. Minutolo, R. Agarwal, and S. Borrelli Prognostic role of ambulatory blood pressure monitoring in patients with non-dialysis CKD Arch Intern Med 171 12 2011 1090 1098
17. R. Agarwal, and M.J. Andersen Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease Kidney Int 69 7 2006 1175 1180
18. R. Agarwal, and M.J. Andersen Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease Am J Nephrol 26 5 2006 503 510
19. F.B. Gabbai, M. Rahman, and B. Hu Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD Clin J Am Soc Nephrol 7 11 2012 1770 1776
20. E.D. Manios, E.A. Koroboki, and G.K. Tsivgoulis Factors influencing white-coat effect Am J Hypertens 21 2 2008 153 158
21. J. Neugarten, A. Acharya, and S.R. Silbiger Effect of gender on the progression of nondiabetic renal disease: a meta-analysis J Am Soc Nephrol 11 2 2000 319 329
22. N. Halbesma, A.H. Brantsma, and S.J. Bakker Gender differences in predictors of the decline of renal function in the general population Kidney Int 74 4 2008 505 512
23. M. Hyvärinen, Q. Qiao, J. Tuomilehto, S. Söderberg, M. Eliasson, and C.D.A. Stehouwer The difference between acute coronary heart disease and ischaemic stroke risk with regard to gender and age in Finnish and Swedish populations Int J Stroke 5 3 2010 152 156
24. E. O'Brien, G. Parati, G. Stergiou for the European Society of Hypertension Working Group on Blood Pressure Monitoring European Society of Hypertension position paper on ambulatory blood pressure monitoring J Hypertens 31 9 2013 1731 1768
25. H. Skali, H. Uno, A.S. Levey, L.A. Inker, M.A. Pfeffer, and S.D. Solomon Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation Am Heart J 162 3 2011 548 554
26. J.D. Kalbfleisch, and R.L. Prentice The Statistical Analysis of Failure Time Data 1980 John Wiley New York, NY
27. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 3 1988 1141 1154
28. H. Putter, M. Fiocco, and R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389 2430
29. B. Lau, S.R. Cole, and S.J. Gange Competing risk regression models for epidemiologic data Am J Epidemiol 170 2009 244 256
30. M. Gorostidi, P.A. Sarafidis, A. de la Sierra for Spanish ABPM Registry Investigators Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: a 5,693-patient cross-sectional analysis from Spain Am J Kidney Dis 62 2 2013 285 294
31. National Kidney Foundation K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 43 suppl 1 2004 S1 S290
32. S. Iimuro, E. Imai, T. Watanabe for the Chronic Kidney Disease Japan Cohort Study Group Clinical correlates of ambulatory BP monitoring among patients with CKD Clin J Am Soc Nephrol 8 5 2013 721 730
33. S.S. Franklin, L. Thijs, T.W. Hansen, E. O'Brien, and J.A. Staessen White-coat hypertension: new insights from recent studies Hypertension 62 6 2013 982 987
34. V.A. Pogue, M. Rahman, M. Lipkowitz for African American Study of Kidney Disease and Hypertension Collaborative Research Group Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease Hypertension 53 1 2009 20 27
35. R.H. Fagard, J.A. Staessen, L. Thijs for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension Circulation 102 10 2000 1139 1144
36. R. Minutolo, S. Borrelli, and R. Scigliano Prevalence and clinical correlates of white coat hypertension in chronic kidney disease Nephrol Dial Transplant 22 8 2007 2217 2223
37. P.E. Drawz, M. Abdalla, and M. Rahman Blood pressure measurement: clinic, home, ambulatory, and beyond Am J Kidney Dis 60 3 2012 449 462
38. National Institute of Health and Clinical Excellence Hypertension: Clinical Management of Primary Hypertension pn Adults 2011 NICE London, UK http://guidance.nice.org.uk/CG127 Accessed March 20, 2014
39. I.Z. Ben-Dov, L. Ben-Arie, J. Mekler, and M. Bursztyn Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring Int J Cardiol 117 3 2007 355 359